Catharine expresses a bullish outlook on the psychedelics market, despite current challenges in scalability and clinical trials. The conversation touches on recent legislative changes, like Oakland's decriminalization of certain psychedelics, and speculates on the potential for national referendums similar to cannabis legalization. Catharine is actively exploring investment opportunities in this evolving space.
